These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents. Yarkoni A, Brodsky A, Sabapathy R, Pershad A. Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306 [Abstract] [Full Text] [Related]
6. Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease. Zhang F, Dong L, Qian J, Ge J. Ann Med; 2011 Feb; 43(1):75-9. PubMed ID: 21171912 [Abstract] [Full Text] [Related]
7. Drug-eluting stents for the treatment of acute myocardial infarction: the view to the HORIZONS. Prasad SB, Ahmar W, Malaiapan Y, Meredith IT. Heart Lung Circ; 2010 Jan; 19(1):11-8. PubMed ID: 20022808 [Abstract] [Full Text] [Related]
10. Status of drug-eluting coronary stents. Chodosh A, Korr KS, Burtt D. Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106 [Abstract] [Full Text] [Related]
11. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN. J Am Coll Cardiol; 2008 Jun 24; 51(25):2385-95. PubMed ID: 18565394 [Abstract] [Full Text] [Related]
12. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Rhee KS, Chae JK, Ko JK, Park JH, Lee JH, Choi SW, Jeong JO, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Kim HS, Park SJ. J Am Coll Cardiol; 2009 Mar 03; 53(9):812-3. PubMed ID: 19245976 [No Abstract] [Full Text] [Related]